EVALUATION OF TUMOR BURDEN RESPONSE TO SINGLE-CYCLE OF Lu-177 PSMA TREATMENT WITH WHOLE BODY SCINTIGRAPHIC PLANAR IMAGES IN PROSTATE CANCER PATIENTS


Acar E., Aksu A., Ellidokuz E. B., Başbınar Y., Kaya G. C.

JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES, sa.1, ss.471-478, 2023 (ESCI) identifier

Özet

Purpose: The aim of this study was to evaluate treatment response and survival with post-therapy images in patients who received one cycle of Lu-177 PSMA I&T treatment. Material and Methods: After Lu-177 PSMA I&T treatment was administered to 54 patients, maximum count, pixel count (tumor extent) and sum (total tumor burden) values were calculated with a semiautomatic program. The images after the first treatment were evaluated as basal disease images. Images obtained after the second treatment were considered the response to the first cycle treatment. Results: It was determined that the number of maximum counts (p: 0.015) and tumor extent (p: 0.014) were significantly reduced after one cycle of Lu177 PSMA treatment. No significant change in total tumor burden (p:0.206) was detected. After one treatment cycle the maximum count in 46% of the patients and the total tumor burden in 63% of the patients. The number of pixels (tumor prevalence) in 41% of the patients decreased by >= 25%. Based on the Naive-Bayes method, one-year survival accuracy was 71.6%. Conclusion: With the texture analysis and machine learning of the Lu-177 PSMA post-therapy images, treatment response and survival were determined with high accuracy.